Scynexis (SCYX) Inventory Average (2021 - 2023)
Scynexis' (SCYX) quarterly Inventory Average came in at $11.7 million in Q3 2023, up 1553.99% on a YoY basis from $707500.0 in Q3 2022, and up 105.39% quarter-over-quarter from $5.7 million in Q2 2023.
Analysis
Scynexis (SCYX) Inventory Average (2021 - 2023) Analysis & Trends
Scynexis (SCYX) has reported Inventory Average for 3 consecutive years, with $11.7 million the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Inventory Average rose 1553.99% year-over-year to $11.7 million; the trailing twelve-month figure through Sep 2023 stood at $11.7 million (up 1553.99% YoY), and the FY2022 full-year result was $681000.0, changed N/A from the prior year.
- Inventory Average climbed to $11.7 million in Q3 2023 per SCYX's latest filing, from $5.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $11.7 million in Q3 2023 and bottomed at $361500.0 in Q3 2021.
- Historically, Inventory Average has averaged $2.5 million across 3 years, with a median of $842500.0 in 2022.
- The widest YoY moves for Inventory Average: up 1553.99% in 2023, down 24.32% in 2023.
- Over 3 years, Inventory Average stood at $547000.0 in 2021, then surged by 54.02% to $842500.0 in 2022, then surged by 1288.96% to $11.7 million in 2023.
- According to Business Quant data, Inventory Average over the past three periods registered $11.7 million, $5.7 million, and $1.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 11.70 Mn |
| Jun 30, 2023 | 5.70 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 842,500.00 |
| Sep 30, 2022 | 707,500.00 |
| Jun 30, 2022 | 889,000.00 |
| Mar 31, 2022 | 806,000.00 |
| Dec 31, 2021 | 547,000.00 |
| Sep 30, 2021 | 361,500.00 |